Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lawrence Marinucci"'
Autor:
Randall T Schapiro, Extension Study Investigators, Francois Bethoux, Andrew D. Goodman, Theodore R Brown, Andrew R. Blight, Ronald A. Cohen, Lawrence Marinucci, Herbert R. Henney
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Background: In Phase 3 double-blind trials (MS-F203 and MS-F204), dalfampridine extended release tablets 10 mg twice daily (dalfampridine-ER; prolonged-release fampridine in Europe; fampridine modified or sustained release elsewhere) improved walking
Autor:
Randall T Schapiro, Ron Cohen, Andrew D. Goodman, Theodore R Brown, Keith R. Edwards, Lauren B. Krupp, Lawrence Marinucci, Andrew R. Blight
Publikováno v:
Annals of neurology. 68(4)
Objective A previous phase 3 study showed significant improvement in walking ability in multiple sclerosis (MS) patients treated with oral, extended-release dalfampridine (4-aminopyridine) 10mg twice daily. The current study was designed to confirm e
Autor:
Jeffrey A. Cohen, Marco A. Rizzo, Ron Cohen, Andrew D. Goodman, Timothy Vollmer, Andrew R. Blight, Lawrence Marinucci, Anne H. Cross
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 13(3)
Objective To determine the safety of sustained-release 4-aminopyridine in subjects with mutiple sclerosis (MS) and to examine dose-related efficacy up to 40 mg twice daily. Method Multicenter, randomized, double-blind, placebo-controlled, study. Foll